Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin

Inclusion Criteria: * Patient with symptoms suggestive for ACS presenting within 48 hours after onset in the ER/ Chest Pain Unit (CPU) * Patient has at least one elevated high-sensitivity troponin I or T value * Chest pain is classified as non-ACS, despite elevated hsTn (e.g. because of missing troponin dynamics) * At least 50 years of age Exclusion Criteria: * Indication for antiplatelet therapy (e.g transient ischemic attack, or stable coronary artery diseases -CAD) or anticoagulation therapy (such as atrial fibrillation) * Indication for anti-lipid therapy * Any evidence of an acute myocardial necrosis (e.g imaging evidence of new regional wall motion abnormality, or significant ST-segment-T wave (ST-T) changes in ECG) * Untreated clinically significant CAD requiring revascularization * Hemoglobin value below 8 mg/d, and/or creatinine kinase ≥3 times ULN, and/or AST or ALT ≥3 times ULN * Active malignancy of any organ system, treated or untreated. Subjects have to be in remission for at least 36 months to be eligible.